Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Deere & Company stock logo
DE
Deere & Company
$405.57
+0.9%
$393.13
$345.55
$450.00
$112.89B1.041.46 million shs930,852 shs
Pfizer Inc. stock logo
PFE
Pfizer
$27.78
-1.4%
$26.92
$25.20
$40.37
$157.28B0.6343.59 million shs65.40 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Deere & Company stock logo
DE
Deere & Company
+0.25%+0.26%-2.56%+3.36%+5.48%
Pfizer Inc. stock logo
PFE
Pfizer
+1.29%+9.82%+5.66%+2.40%-26.81%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Deere & Company stock logo
DE
Deere & Company
3.6558 of 5 stars
2.33.02.51.52.51.71.3
Pfizer Inc. stock logo
PFE
Pfizer
4.9909 of 5 stars
4.23.04.24.83.71.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Deere & Company stock logo
DE
Deere & Company
2.50
Moderate Buy$433.286.83% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.38
Hold$36.0029.61% Upside

Current Analyst Ratings

Latest PFE and DE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2024
Pfizer Inc. stock logo
PFE
Pfizer
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$28.00 ➝ $29.00
5/2/2024
Pfizer Inc. stock logo
PFE
Pfizer
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$33.00 ➝ $36.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/12/2024
Deere & Company stock logo
DE
Deere & Company
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$415.00 ➝ $425.00
4/1/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
3/22/2024
Pfizer Inc. stock logo
PFE
Pfizer
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
3/14/2024
Deere & Company stock logo
DE
Deere & Company
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$494.00
3/1/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
2/23/2024
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$36.00
2/20/2024
Deere & Company stock logo
DE
Deere & Company
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$381.00 ➝ $387.00
2/16/2024
Deere & Company stock logo
DE
Deere & Company
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$425.00 ➝ $401.00
(Data available from 5/7/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Deere & Company stock logo
DE
Deere & Company
$61.25B1.84$42.74 per share9.49$75.66 per share5.36
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.69$2.97 per share9.34$15.81 per share1.76

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Deere & Company stock logo
DE
Deere & Company
$10.17B$34.3411.8115.191.5116.38%44.60%9.78%5/17/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B-$0.06N/A10.101.17-0.56%8.58%3.70%8/6/2024 (Estimated)

Latest PFE and DE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024Q1 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.56$0.82+$0.26$1.09$13.87 billion$14.88 billion    
2/15/2024Q1 24
Deere & Company stock logo
DE
Deere & Company
$5.19$6.23+$1.04$6.23$10.30 billion$10.49 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Deere & Company stock logo
DE
Deere & Company
$5.881.45%+20.51%17.12%3 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.05%+2.57%N/A 15 Years

Latest PFE and DE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/9/20245/10/20246/14/2024
2/28/2024
Deere & Company stock logo
DE
Deere & Company
quarterly$1.471.61%3/27/20243/29/20245/8/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Deere & Company stock logo
DE
Deere & Company
1.81
2.05
1.81
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Deere & Company stock logo
DE
Deere & Company
68.58%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Deere & Company stock logo
DE
Deere & Company
0.26%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Deere & Company stock logo
DE
Deere & Company
83,000278.36 million277.63 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable

PFE and DE Headlines

SourceHeadline
Pfizer reports patient death in Duchenne gene therapy studyPfizer reports patient death in Duchenne gene therapy study
reuters.com - May 7 at 5:04 PM
Pfizer (NYSE:PFE) Trading Up 0.5%Pfizer (NYSE:PFE) Trading Up 0.5%
marketbeat.com - May 7 at 3:52 PM
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in HealthcareBiotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
investorplace.com - May 7 at 2:04 PM
Is Pfizer Stock Fully Valued At $28?Is Pfizer Stock Fully Valued At $28?
forbes.com - May 7 at 12:30 PM
Pfizer First Quarter 2024 Earnings: Beats ExpectationsPfizer First Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - May 7 at 12:30 PM
Pfizer: Solid Earnings, But Were Not Out Of The Woods YetPfizer: Solid Earnings, But We're Not Out Of The Woods Yet
seekingalpha.com - May 7 at 4:32 AM
Welch & Forbes LLC Reduces Stock Position in Pfizer Inc. (NYSE:PFE)Welch & Forbes LLC Reduces Stock Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - May 7 at 12:17 AM
Pfizer (NYSE:PFE) Stock Price Up 0.8%Pfizer (NYSE:PFE) Stock Price Up 0.8%
marketbeat.com - May 6 at 7:33 PM
Andrew Baum To Oversee Pfizers Innovation, Portfolio StrategyAndrew Baum To Oversee Pfizer's Innovation, Portfolio Strategy
markets.businessinsider.com - May 6 at 7:16 PM
Pfizer: Ignore The Dead Cat BouncePfizer: Ignore The Dead Cat Bounce
seekingalpha.com - May 6 at 7:16 PM
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
finance.yahoo.com - May 6 at 7:16 PM
Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ YieldsMaximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields
investorplace.com - May 6 at 2:22 PM
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to KnowInvestors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
zacks.com - May 6 at 10:01 AM
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings ReportPfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
marketbeat.com - May 6 at 8:58 AM
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of yearUPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
finance.yahoo.com - May 6 at 7:38 AM
Pfizer Announces New Chief Strategy and Innovation OfficerPfizer Announces New Chief Strategy and Innovation Officer
businesswire.com - May 6 at 6:45 AM
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings ReportPfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
marketbeat.com - May 6 at 6:10 AM
Revive Your Portfolio: 3 Undervalued Stocks Poised for GrowthRevive Your Portfolio: 3 Undervalued Stocks Poised for Growth
investorplace.com - May 6 at 6:00 AM
Pfizer Inc. Expected to Earn FY2024 Earnings of $2.15 Per Share (NYSE:PFE)Pfizer Inc. Expected to Earn FY2024 Earnings of $2.15 Per Share (NYSE:PFE)
americanbankingnews.com - May 6 at 3:16 AM
Pfizer Inc. (NYSE:PFE) to Post Q2 2024 Earnings of $0.48 Per Share, Leerink Partnrs ForecastsPfizer Inc. (NYSE:PFE) to Post Q2 2024 Earnings of $0.48 Per Share, Leerink Partnrs Forecasts
americanbankingnews.com - May 6 at 2:44 AM
Pfizer Inc. (NYSE:PFE) Shares Purchased by Metis Global Partners LLCPfizer Inc. (NYSE:PFE) Shares Purchased by Metis Global Partners LLC
marketbeat.com - May 6 at 12:35 AM
3 No-Brainer Stocks to Buy in May3 No-Brainer Stocks to Buy in May
fool.com - May 5 at 6:55 AM
Pfizer (NYSE:PFE)  Shares Down 0.3% Pfizer (NYSE:PFE) Shares Down 0.3%
americanbankingnews.com - May 5 at 4:38 AM
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming DividendDo These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
finance.yahoo.com - May 4 at 6:18 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Deere & Company logo

Deere & Company

NYSE:DE
Deere & Company engages in the manufacture and distribution of various equipment worldwide. The company operates through four segments: Production and Precision Agriculture, Small Agriculture and Turf, Construction and Forestry, and Financial Services. The Production and Precision Agriculture segment provides large and medium tractors, combines, cotton pickers and strippers, sugarcane harvesters and loaders, harvesting front-end equipment, pull-behind scrapers, and tillage and seeding equipment, as well as application equipment, including sprayers and nutrient management, and soil preparation machinery for grain growers. The Small Agriculture and Turf segment offers utility tractors, and related loaders and attachments; turf and utility equipment, including riding lawn equipment, commercial mowing equipment, golf course equipment, and utility vehicles, as well as implements for mowing, tilling, snow and debris handling, aerating, residential, commercial, golf, and sports turf care applications; other outdoor power products; and hay and forage equipment. This segment also resells products from other manufacturers. It serves dairy and livestock producers, crop producers, and turf and utility customers. The Construction and Forestry segment provides a range of backhoe loaders, crawler dozers and loaders, four-wheel-drive loaders, excavators, motor graders, articulated dump trucks, landscape and skid-steer loaders, milling machines, pavers, compactors, rollers, crushers, screens, asphalt plants, log skidders, log feller bunchers, log loaders and forwarders, log harvesters, and attachments; and roadbuilding equipment. The Financial Services segment finances sales and leases agriculture and turf, and construction and forestry equipment. It also offers wholesale financing to dealers of the foregoing equipment; and extended equipment warranties, as well as finances retail revolving charge accounts. The company was founded in 1837 and is headquartered in Moline, Illinois.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.